A PHASE III RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED TRIAL TO EVALUATETHE EFFICACY AND SAFETY OF PRM-151 INPATIENTS WITH IDIOPATHIC PULMONARYFIBROSIS

Project: Research project

Project Details

Description

A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
StatusActive
Effective start/end date9/15/209/15/23

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.